Clinical Trial Update: An Extension Study to Evaluate the Long Term Safety, Tolerability and Efficacy of Aliskiren Compared to Enalapril in Pediatric Hypertensive Patients 6-17 Years of Age [Phase 3]

View source ↗

Summary

This Phase 3 extension study in pediatric patients aged 6-17 with hypertension evaluates long-term safety, tolerability, and efficacy of aliskiren compared with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Aliskiren (Aliskiren)
• Enalapril (enalapril)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Hypertension | Phase 3 | Status: COMPLETED | Results posted: 2016-03-07